Podder Mohua, Ruan Jian, Tripp Ben W, Chu Zane E, Tebbutt Scott J
The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St, Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.
BMC Med Genomics. 2008 Jan 31;1:5. doi: 10.1186/1755-8794-1-5.
Arrayed primer extension (APEX) is a microarray-based rapid minisequencing methodology that may have utility in 'personalized medicine' applications that involve genetic diagnostics of single nucleotide polymorphisms (SNPs). However, to date there have been few reports that objectively evaluate the assay completion rate, call rate and accuracy of APEX. We have further developed robust assay design, chemistry and analysis methodologies, and have sought to determine how effective APEX is in comparison to leading 'gold-standard' genotyping platforms. Our methods have been tested against industry-leading technologies in two blinded experiments based on Coriell DNA samples and SNP genotype data from the International HapMap Project.
In the first experiment, we genotyped 50 SNPs across the entire 270 HapMap Coriell DNA sample set. For each Coriell sample, DNA template was amplified in a total of 7 multiplex PCRs prior to genotyping. We obtained good results for 41 of the SNPs, with 99.8% genotype concordance with HapMap data, at an automated call rate of 94.9% (not including the 9 failed SNPs). In the second experiment, involving modifications to the initial DNA amplification so that a single 50-plex PCR could be achieved, genotyping of the same 50 SNPs across each of 49 randomly chosen Coriell DNA samples allowed extremely robust 50-plex genotyping from as little as 5 ng of DNA, with 100% assay completion rate, 100% call rate and >99.9% accuracy.
We have shown our methods to be effective for robust multiplex SNP genotyping using APEX, with 100% call rate and >99.9% accuracy. We believe that such methodology may be useful in future point-of-care clinical diagnostic applications where accuracy and call rate are both paramount.
引物延伸微阵列分析(APEX)是一种基于微阵列的快速微测序方法,在涉及单核苷酸多态性(SNP)基因诊断的“个性化医疗”应用中可能具有实用价值。然而,迄今为止,很少有报告客观评估APEX的检测完成率、检出率和准确性。我们进一步开发了稳健的检测设计、化学和分析方法,并试图确定与领先的“金标准”基因分型平台相比,APEX的效果如何。我们的方法在两项基于Coriell DNA样本和国际人类基因组单体型图计划(International HapMap Project)的SNP基因型数据的盲法实验中,与行业领先技术进行了测试。
在第一个实验中,我们对整个270个HapMap Coriell DNA样本集的50个SNP进行了基因分型。对于每个Coriell样本,在基因分型之前,总共通过7次多重PCR扩增DNA模板。我们对41个SNP获得了良好的结果,与HapMap数据的基因型一致性为99.8%,自动检出率为94.9%(不包括9个失败的SNP)。在第二个实验中,对初始DNA扩增进行了改进,以便能够实现单次50重PCR,对49个随机选择的Coriell DNA样本中的每一个进行相同的50个SNP的基因分型,仅需5 ng DNA就能实现极其稳健的50重基因分型,检测完成率为100%,检出率为100%,准确率>99.9%。
我们已经证明我们的方法对于使用APEX进行稳健的多重SNP基因分型是有效的,检出率为100%,准确率>99.9%。我们相信,这种方法在未来准确性和检出率都至关重要的即时医疗临床诊断应用中可能会很有用。